Real people, real stories

Meet amazing people sharing personal stories about their journeys living with schizophrenia

Avary is taking COBENFY. Avary and Ashleigh were compensated for their time.

Real people taking COBENFY

COBENFY was studied in two 5-week clinical studies with 470 adults with schizophrenia aged 18 to 65 who either took COBENFY or a sugar pill. A rating scale measured changes in schizophrenia symptoms overall. Individual symptom changes were not studied. Results may vary.

Avary, an actual COBENFY (xanomeline and trospium chloride) patient, getting ready to swing a baseball bat

“Because my symptoms have improved…I’m able to do things like read a book.”

Meet Avary, who is taking COBENFY for his schizophrenia. See how Avary, with support from his care partner and wife Ashleigh, is BEcoming his own inspiration.

Avary is sharing his individual experiences; Avary and Ashleigh were compensated for their time. Results may vary.

Image of Rosie, an actual COBENFY (xanomeline and trospium chloride) patient

“I’ve noticed that my overall symptoms have improved. I’m excited to continue on COBENFY.”

Meet Rosie, who is taking COBENFY and experiencing improvement in her schizophrenia symptoms overall.

Rosie is sharing her individual experiences; Rosie and Fran were compensated for their time. Results may vary.

Real conversations about schizophrenia

Meet patients living with schizophrenia and learn how they navigate the various aspects of their journey.

The people featured in these videos are sharing their individual experiences with schizophrenia. Not all of those featured are currently taking COBENFY. Individual experiences with the condition and treatment may vary.

Older woman in a white shirt and brown cardigan looking into the camera

Jia is not taking COBENFY and was compensated for her time.

Supporting a loved one

Watch Jia discuss how she supports her daughter, Kelsey, and the importance of feeling supported herself.

Brunette woman in a green shirt smiling into the camera

Chayilee is not taking COBENFY and was compensated for her time.

Personal strategies

Watch real stories about how daily habits and hobbies can make a big difference in managing schizophrenia.

Older man with glasses and a salt-and-pepper colored beard looking into the camera

Albert is taking COBENFY and was compensated for his time.

Being supported

Hear how real people with schizophrenia find ways to feel supported and what it means to them.

Wavy-haired woman in a pink shirt looking into the camera

Kelsey is not taking COBENFY and was compensated for her time.

Starting conversations

People living with schizophrenia share the importance of having open conversations with their healthcare providers—and different ways they’ve approached it.

/

Take your next step with COBENFY

Understand why COBENFY is different*

COBENFY was designed with a different approach in mind.

Dive into COBENFY results

Explore how COBENFY performed in 2 clinical studies with patients living with schizophrenia.

* A muscarinic agonist (xanomeline) and muscarinic antagonist (trospium chloride). The way that COBENFY works is not fully understood.

Share your story

People living with schizophrenia want to hear your experiences with COBENFY.

Albert is taking COBENFY and was compensated for his time.



Cobenfy, Cobenfy Cares, and the Cobenfy logo are trademarks of Karuna Therapeutics, Inc., a Bristol Myers Squibb company.
© 2026 Bristol-Myers Squibb Company. 
1629-US-2600002 01/26
This website is intended for U.S. residents 18 years of age or older.